SONA-PHARM OÜRegistered
Qualified audit opinion. 2023 report: Qualified.
Key figures
36 914 000 €+2,9%
Revenue 2025
+51,7%
Average annual growth 2019–2025
Ratios
202514,7%
Profit margin
17,8%
EBITDA margin
37,5%
Equity ratio
1,6×
Current ratio
54,9%
Return on equity
14 312 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 2 136 240 € | 5 | 123 974 € |
| Q1 2026 | 806 061 € | 4 | 71 825 € |
| Q4 2025 | 454 113 € | 3 | 75 695 € |
| Q3 2025 | 125 410 € | 3 | 71 592 € |
| Q2 2025 | 1 760 377 € | 3 | 75 639 € |
| Q1 2025 | 1 373 260 € | 3 | 118 235 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
Distributed as dividends 3 923 000 € (47% of distributable profit).
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 † | 2021 † | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 1 590 000 | — | — | — | — | 23 711 000 | 26 007 000 |
| Total non-current assets | 64 000 | — | — | — | — | 111 000 | 374 000 |
| Total assets | 1 654 000 | 2 771 000 | 4 416 000 | 10 807 000 | 12 946 000 | 23 822 000 | 26 381 000 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 565 000 | — | — | — | — | 15 437 000 | 16 308 000 |
| Non-current liabilities | — | — | — | — | — | 6000 | 187 000 |
| Total liabilities | 565 000 | — | — | — | — | 15 443 000 | 16 495 000 |
| Share capital | 26 000 | — | — | — | — | 26 000 | 26 000 |
| Retained earnings of previous periods | 406 000 | — | — | — | — | 1 410 000 | 4 430 000 |
| Profit for the year | 657 000 | — | — | — | — | 6 943 000 | 5 430 000 |
| Total equity | 1 089 000 | — | — | — | — | 8 379 000 | 9 886 000 |
| Income statement | |||||||
| Sales revenue | 3 031 000 | 4 648 000 | 4 552 000 | 5 701 000 | 7 969 000 | 35 874 000 | 36 914 000 |
| Operating profit | 694 000 | — | — | — | — | 7 054 000 | 6 526 000 |
| EBITDA | — | — | — | — | — | 7 076 000 | 6 556 000 |
| Profit before income tax | 703 000 | — | — | — | — | 7 022 000 | 6 558 000 |
| Profit for the reporting year | 657 000 | — | — | — | — | 6 943 000 | 5 430 000 |
| Labour costs | 33 000 | — | — | — | — | 801 000 | — |
| Depreciation of non-current assets | — | — | — | — | — | 22 000 | 30 000 |
| Other indicators | |||||||
| Employees | 2 | 2 | 2 | 3 | 5 | 5 | 7 |
| Calculated dividend | — | — | — | — | — | — | 3 923 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report. † Figures for the marked years come from a report filed as PDF and may be incomplete.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Ravimite ja muude apteegikaupade hulgimüük